E2: Evidence and Expert Insights in Adjunctive Treatment of Major Depressive Disorder

E2: Evidence and Expert Insights in Adjunctive Treatment of Major Depressive Disorder is organized by Postgraduate Institute for Medicine (PIM). The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.

Release Date: November 20, 2019
Valid for credit through November 20, 2020

Learning Objectives:
After completing this activity, the participant should be better able to:
• Review data on current and emerging treatments for MDD patients with inadequate response to initial antidepressant treatment
• Apply current evidence to support the appropriate use of adjunctive therapies in MDD patients with inadequate response to antidepressant therapy

Additional details will be posted as soon as information is available.